The DOI matches its Crossref record; 57 of the 62 references it cites were found in a registry or an index.
Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage
Open accessAbstract
Objective To analyse the relations between the urinary levels of type II collagen C-telopeptide (CTX-II) and glucosyl-galactosyl pyridinoline (Glc-Gal-PYD)-two newly developed biochemical markers of type II collagen and synovial tissue destruction respectively-disease activity and the severity of joint destruction in patients with knee osteoarthritis (OA). The clinical performance of these two new markers was compared with that of a panel of other established biochemical markers of connective tissue metabolism. Methods The following biochemical markers were measured in a group of 67 patients with knee OA (mean age 64 years, median disease duration eight years ) and in 67 healthy controls: for bone, serum osteocalcin, serum and urinary C-telopeptide of type I collagen (CTX-I); for cartilage, urinary CTX-II, serum cartilage oligomeric matrix protein (COMP), and serum human cartilage glycoprotein 39 (YKL-40); for synovium, urinary Glc-Gal-PYD, serum type III collagen N-propeptide (PIIINP), serum hyaluronic acid (HA); and for inflammation, serum C reactive protein. Biochemical markers were correlated with pain and physical function (WOMAC index) and with quantitative radiographic evaluation of the joint space using the posteroanterior view of the knees flexed at 30 degrees. Results All bone turnover markers were decreased in patients with knee OA compared with controls (-36%, -38%, and -52%, p<0.0001 for serum osteocalcin, serum CTX-I and urinary CTX-I, respectively). Serum COMP (+16%, p=0.0004), urinary CTX-II (+25%, p=0.0009), urinary Glc-Gal-PYD (+18%, p=0.028), serum PIIINP (+33%, p<0.0001), and serum HA (+ 233%, p<0.0001) were increased. By univariate analyses, increased urinary Glc-Gal-PYD (r=0.41, p=0.002) and decreased serum osteocalcin (r=-0.30, p=0.025) were associated with a higher total WOMAC index. Increased urinary CTX-II (r=-0.40, p=0.0002) and Glc-Gal-PYD (r=-0.30, p=0.0046) and serum PIIINP (r=-0.29, p=0.0034) were the only markers which correlated with joint surface area. By multivariate analyses, urinary Glc-Gal-PYD and CTX-II were the most important predictors of the WOMAC index and joint damage, respectively. Conclusion Knee OA appears to be characterised by a systemic decrease of bone turnover and increased cartilage and synovial tissue turnover. CTX-II, Glc-Gal-PYD, and PIIINP may be useful markers of disease severity in patients with knee OA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Though inter-laboratory standardization and age/sex/ethnicity-stratified reference ranges remain challenges for broad adoption”
From Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease (2025) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Garnero, P., Sornay‐Rendu, E., Chapuy, M. C., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110307 · Cited by 1,000
Self-citationEnhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C. H., Mitchell, P. G., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 970
Hakala, B. E., White, C., & Recklies, A. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74461-5 · Cited by 643
Hollander, A. P., Heathfield, T. F., Webber, C. A., Iwata, Y., Bourne, R., Rorabeck, C. H., & Poole, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117156 · Cited by 611
ROLE OF MECHANICAL FACTORS IN PATHOGENESIS OF PRIMARY OSTEOARTHRITIS
Radin, E., Paul, I., & Rose, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90179-1 · Cited by 595
Dieppe, P. A., Cushnaghan, J., Young, P. J., & Kirwan, J. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.8.557 · Cited by 428
Spector, T. D., Hart, D. J., Nandra, D., Doyle, D. V., Mackillop, N., Gallimore, J. R., & Pepys, M. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400419 · Cited by 403
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.
Risteli, J., Niemi, S., Trivedi, P., Mäentausta, O., Mowat, A. P., & Risteli, L. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.4.715 · Cited by 336
Flagged first, then by citations
5 of the 62 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Otterness, 1999, Measurement of type II collagen neoepitope (uTIINE) levels in rheumatoid arthritis (RA) patients to assess joint status [abstract]., Arthritis Rheum, 42(suppl 9), S249
- Moskowitz, 1998, Type II C-telopeptide 2B4 epitope is a marker for cartilage degradation in familial osteoarthritis [abstract]., Arthritis Rheum, 41(suppl 9), S352
- Hellio, 1996, Assessment of urinary hydroxypyridinium crosslink measurements in osteoarthritis., BMJ, 35, 1091
Cited by
Sorted by citations
Items 101–200 of 475
van Spil, W. E., Welsing, P. M. J., Bierma‐Zeinstra, S., Bijlsma, J. W. J., Roorda, L. D., Cats, H. A., & Lafeber, F. P. J. G. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.03.023 · Cited by 50
Cooper, C. C., Reginster, J., Chapurlat, R. D., Christiansen, C., Genant, H. K., Bellamy, N., Bensen, W., Navarro, F., Badurski, J. E., Nasonov, E. L., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.648758 · Cited by 51
Chmielewski, T. L., Trumble, T. N., Joseph, A.-M., Shuster, J. J., Indelicato, P. A., Moser, M. W., Cicuttini, F., & Leeuwenburgh, C. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.07.014 · Cited by 49
Celik, O., Salcı, Y., Ak, E., Kalacı, A., & Korkusuz, F. (2012) · The Knee · doi:10.1016/j.knee.2012.06.001 · Cited by 50
Punzi, L., Oliviero, F., & Plebani, M. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360591001886 · Cited by 49
Liem, Y., Judge, A., Kirwan, J., Ourradi, K., Li, Y., & Sharif, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68077-0 · Cited by 49
Type II collagen peptides for measuring cartilage degradation.
Henrotin, Y. E., Deberg, M. A., Dubuc, J.-E., Quettier, E., Christgau, S., & Reginster, J.-Y. (2004) · PubMed · Cited by 49
Self-citationHunt, M. A., Pollock, C. L., Kraus, V. B., Saxne, T., Peters, S., Huebner, J. L., Sayre, E. C., & Cibere, J. (2013) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-14-115 · Cited by 48
Bertuglia, A., Pagliara, E., Grego, E., Ricci, A. L., & Brkljača-Bottegaro, N. (2016) · BMC Veterinary Research · doi:10.1186/s12917-016-0873-7 · Cited by 48
Cheng, H., Hao, B., Sun, J., & Yin, M. (2018) · Cartilage · doi:10.1177/1947603518798884 · Cited by 48
Conrozier, T., Balblanc, J., Richette, P., Mulleman, D., Maillet, B., Henrotin, Y. E., Rannou, F., Piroth, C., Hilliquin, P., Mathieu, P., et al. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21580 · Cited by 47
Self-citationRaut, R. D., Chakraborty, A. K., Neogi, T., Albro, M. B., Snyder, B. D., Schaer, T. P., Zhang, C., Grinstaff, M. W., & Bais, M. V. (2025) · Communications Biology · doi:10.1038/s42003-025-08586-8 · Cited by 54
Rego‐Pérez, I., Fernández-Moreno, M., Deberg, M. A., Pértega-Díaz, S., Fernández-López, C., Oreiro, N., Henrotin, Y. E., & Blanco, F. J. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.133637 · Cited by 46
Larsson, S., Englund, M., Struglics, A., & Lohmander, S. L. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3217 · Cited by 46
Conrozier, T., Poole, A. R., Ferrand, F., Mathieu, P., Vincent, F., Piperno, M., Verret, C., Ionescu, M., & Vignon, E. P. (2008) · PubMed · Cited by 46
Self-citationMolecular markers for osteoarthritis: the road ahead
DeGroot, J., Bank, R. A., Tchetverikov, I., Verzijl, N., & TeKoppele, J. M. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00019 · Cited by 46
Kumm, J., Tamm, A. O., Lintrop, M., & Tamm, A. O. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.03.008 · Cited by 45
Correlates of knee pain in younger subjects
Zhai, G., Cicuttini, F., Ding, C., Scott, F. S., Garnero, P., & Jones, G. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0248-8 · Cited by 45
Self-citationProtein biomarkers associated with pain mechanisms in osteoarthritis
Thudium, C. S., Löfvall, H., Karsdal, M. A., Bay‐Jensen, A., & Bihlet, A. R. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.04.030 · Cited by 44
Lim, Y. Z., Wang, Y., Wluka, A. E., Davies-Tuck, M. L., Hanna, F. S., Urquhart, D. M., & Cicuttini, F. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.10.006 · Cited by 42
Tanishi, N., Yamagiwa, H., Mera, H., Endo, N., Hayami, T., Koga, Y., & Omori, G. (2014) · Journal of Orthopaedic Science · doi:10.1007/s00776-014-0535-1 · Cited by 42
Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis
Min, S., Shi, T., Han, X., Chen, D., Xu, Z., Shi, D., Teng, H., & Jiang, Q. Y. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05150-z · Cited by 46
Human cartilage glycoprotein 39—biomarker of joint damage in knee osteoarthritis
Živanović, S., Petrović-Rackov, L., Vojvodić, D., & Vučetić, D. D. (2009) · International Orthopaedics · doi:10.1007/s00264-009-0747-8 · Cited by 42
Osteoporosis and bone metabolism in postmenopausal women with osteoarthritis of the hand
Zoli, A., Lizzio, M. M., Capuano, A., Massafra, U., Barini, A., & Ferraccioli, G. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000179048.08371.8e · Cited by 42
Berry, P., Maciewicz, R. A., Cicuttini, F., JONES, M. D., Hellawell, C. J., & Wluka, A. E. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091055 · Cited by 42
The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation
Görgens, S. W., Hjorth, M., Eckardt, K., Wichert, S., Norheim, F., Holen, T., Lee-Ødegård, S., Langleite, T. M., Birkeland, K. I., Stadheim, H. K., et al. (2015) · Acta Physiologica · doi:10.1111/apha.12579 · Cited by 42
Zhang, J. J. (2018) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-018-1932-y · Cited by 42
Collagen biomarkers for arthritis applications.
Birmingham, J. D., Vilı́m, V., & Kraus, V. B. (2007) · PubMed Central · Cited by 41
van Spil, W. E., Nair, S. C., Kinds, M. B., Emans, P. J., Hilberdink, W. K., Welsing, P. M. J., & Lafeber, F. P. J. G. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.09.003 · Cited by 41
Wang, T. J., Larson, M. G., Benjamin, E. J., Siwik, D. A., Safa, R., Guo, C., Corey, D., Sundström, J., Sawyer, D. B., Colucci, W. S., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.006 · Cited by 41
Wang, S., Mo, S., Chung, R. C. K., Shull, P. B., Ribeiro, D. C., & Cheung, R. T. H. (2020) · Arthritis Care & Research · doi:10.1002/acr.24420 · Cited by 40
Rego‐Pérez, I., Fernández-Moreno, M., Deberg, M. A., Pértega-Díaz, S., Fernández-López, C., Oreiro, N., Henrotin, Y. E., & Blanco, F. J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117416 · Cited by 41
Afara, I. O., Prasadam, I., Crawford, R., Xiao, Y., & Oloyede, A. (2012) · Bone · doi:10.1016/j.bone.2012.12.042 · Cited by 41
Ravn, P., Warming, L., Christgau, S., & Christiansen, C. (2004) · Bone · doi:10.1016/j.bone.2004.07.017 · Cited by 40
Self-citationBay‐Jensen, A., Tabassi, N. C.-B., Søndergaard, L. V., Andersen, T. L., Dagnæs‐Hansen, F., Garnero, P., Kassem, M. S., & Delaissé, J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2596 · Cited by 39
Self-citationPark, M., Chung, S.-J., Park, Y., & Lee, S.-K. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.2.288 · Cited by 39
Jiao, Q., Lei, W., Chen, C., Li, P., Wang, X., Li, Y., Guo, L., Zhang, C., & Wei, X. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1118547 · Cited by 39
Rationale for the potential use of calcitonin in osteoarthritis.
Manicourt, D.-H., Devogelaer, J. P., Azria, M., & Silverman, S. L. (2005) · PubMed · Cited by 39
Fernández-Moreno, M., Soto‐Hermida, A., Pértega-Díaz, S., Oreiro, N., Fernández-López, C., Rego‐Pérez, I., & Blanco, F. J. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-264 · Cited by 39
Bone Mineral Density is Lower in Patients with Severe Knee Osteoarthritis and Attrition
Linde, K. N., Puhakka, K. B., Langdahl, B. L., Søballé, K., Krog-Mikkelsen, I., Madsen, F., & Stilling, M. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0315-y · Cited by 39
Cartilage Oligomeric Matrix Protein - inflammation biomarker in knee osteoarthritis
Živanović, S., Petrović-Rackov, L., Živanović, A., Jevtić, M., Nikolić, S., & Kocic, S. S. (2011) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2011.2619 · Cited by 37
Application of biochemical markers in development of drugs for treatment of osteoarthritis
Qvist, P., Christiansen, C., Karsdal, M. A., Madsen, S. H., Sondergaard, B. C., & Bay‐Jensen, A. (2009) · Biomarkers · doi:10.3109/13547500903295873 · Cited by 38
Bartels, E. M., Christensen, R., Christensen, P., Henriksen, M., Bennett, A. N., Gudbergsen, H., Boesen, M., & Bliddal, H. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.07.027 · Cited by 45
Jung, S., Oh, M., Lee, D., Lee, Y., Kim, G., Park, S., Han, S.-K., Kim, Y.-O., Yoon, S., & Chae, S. (2021) · Nutrients · doi:10.3390/nu13103352 · Cited by 35
Ebrahimpour‐Koujan, S., Sohrabpour, A. A., Giovannucci, E. L., Vatannejad, A., & Esmaillzadeh, A. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00911-x · Cited by 40
Ji, Q., Wang, P., & He, C. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.07.001 · Cited by 36
Kumm, J., Tamm, A. E., Lintrop, M., & Tamm, A. O. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9302-2 · Cited by 35
Tanishi, N., Yamagiwa, H., Hayami, T., Mera, H., Koga, Y., Omori, G., & Endo, N. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0077-3 · Cited by 33
Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside
Zou, Z., Luo, X., Chen, Z., Zhang, Y. S., & Wen, C. (2021) · Theranostics · doi:10.7150/thno.62685 · Cited by 33
Nagaoka (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000257 · Cited by 31
Sasaki, E., Tsuda, E., Yamamoto, Y., Iwasaki, K., Inoüe, R., Takahashi, I., Sawada, K., Fujita, H., Umeda, T., Nakaji, S., et al. (2013) · International Orthopaedics · doi:10.1007/s00264-013-1849-x · Cited by 32
Manicourt, D.-H., Bevilacqua, M. T., Righini, V., Famaey, J. P., & Devogelaer, J. (2005) · Drugs in R&D · doi:10.2165/00126839-200506050-00002 · Cited by 32
Can urinary CTX-II be a biomarker for knee osteoarthritis?
Arunrukthavon, P., Heebthamai, D., Benchasiriluck, P., Chaluay, S., Chotanaphuti, T., & Khuangsirikul, S. (2020) · Arthroplasty · doi:10.1186/s42836-020-0024-2 · Cited by 31
YKL-40: A New Biomarker in Cardiovascular Disease?
Mathiasen, A. B., Henningsen, K. M. A., Harutyunyan, M., Mygind, N. D., & Kastrup, J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.58 · Cited by 31
Lekpa, F. K., Pietté, J. C., Bastuji‐Garin, S., Kraus, V. B., Stäbler, T., Poole, A. R., Marini-Portugal, A., & Chevalier, X. (2010) · PubMed · Cited by 30
Huang, M., Zhao, J., Huang, Y., Dai, L., & Zhang, X. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.06.005 · Cited by 29
Bone Metabolism in Postmenopausal Women With Lumbar Spinal Stenosis
Kim, H., Lee, H., Kim, H., Park, J., Moon, E. S., Park, H., Park, S.-Y., & Moon, S.-H. (2008) · Spine · doi:10.1097/brs.0b013e3181829fca · Cited by 29
Collagen Biomarkers for Arthritis Applications
Birmingham, J. D., Vilı́m, V., & Kraus, V. B. (2006) · Biomarker Insights · doi:10.1177/117727190600100011 · Cited by 29
Røtterud, J. H., Reinholt, F. P., Beckstrøm, K. J., Risberg, M. A., & Årøen, A. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-99 · Cited by 28
Koca, İ., Boyacı, A., Tutoğlu, A., Boyacı, N., & Özkur, A. (2014) · Journal of Physical Therapy Science · doi:10.1589/jpts.26.931 · Cited by 28
Ramprasath, V. R., Shanthi, P., & Sachdanandam, P. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.11.009 · Cited by 27
Niki, Y., Takeuchi, T., Nakayama, M., Nagasawa, H., Kurasawa, T., Yamada, H., Toyama, Y., & Miyamoto, T. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037447 · Cited by 27
Kumagai, K., Toyoda, F., Staunton, C. A., Maeda, T., Okumura, N., Matsuura, H., Matsusue, Y., Imai, S., & Barrett‐Jolley, R. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.05.019 · Cited by 27
Watari, T., Naito, K., Sakamoto, K., Kurosawa, H., Nagaoka, I., & Kaneko, K. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.196 · Cited by 30
Goode, A. P., Nelson, A. E., Kraus, V. B., Renner, J. B., & Jordan, J. M. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.07.007 · Cited by 26
Biomarkers for Osteoarthritis Diseases
Braaten, J. A., Banovetz, M. T., DePhillipo, N. N., Familiari, F., Russo, R., Kennedy, N. I., & LaPrade, R. F. (2022) · Life · doi:10.3390/life12111799 · Cited by 26
Role of Hyaluronic Acid in Early Diagnosis of Knee Osteoarthritis
Singh, S. K. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/11732.5342 · Cited by 27
Biochemical Markers of Joint Tissue Turnover
Bay‐Jensen, A., Sondergaard, B. C., Christiansen, C., Karsdal, M. A., Madsen, S. H., & Qvist, P. (2009) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0199 · Cited by 27
Joint and bone assessment in hand osteoarthritis
Ramonda, R., Frallonardo, P., Musacchio, E., Vio, S., & Punzi, L. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2404-2 · Cited by 26
Chitinase-like Proteins in Lung Injury, Repair, and Metastasis
Lee, C. G., Cruz, C. S. D., Ma, B., Ahangari, F., Zhou, Y., Halaban, R., Sznol, M., & Elias, J. A. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201112-056ms · Cited by 25
Dündar, Ü., Aşık, G., Ulaşlı, A. M., Sınıcı, Ş., Yaman, F., Solak, Ö., Toktaş, H., & Eroğlu, S. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12565 · Cited by 25
Vertti, R. D. A. P., AGUILAR, L. S., ARGÜELLO, R., HERNADEZ, F., GONZALEZ, F. F., & Morán‐Martínez, J. (2017) · Archives of Rheumatology · doi:10.5606/archrheumatol.2017.6220 · Cited by 25
Mitochondrial Haplogroups Define Two Phenotypes of Osteoarthritis
Fernández-Moreno, M., Soto‐Hermida, A., Oreiro, N., Pértega-Díaz, S., Fernández-López, C., Rego‐Pérez, I., & Blanco, F. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00129 · Cited by 25
Conrozier, T., Ferrand, F., Poole, A. R., Verret, C., Mathieu, P., Ionescu, M., Vincent, F., Piperno, M., Spiegel, A., & Vignon, E. P. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.09.002 · Cited by 25
Self-citationHoch, J. M., Mattacola, C. G., Bush, H., McKeon, J. M. M., Hewett, T. E., & Lattermann, C. M. (2012) · The American Journal of Sports Medicine · doi:10.1177/0363546512458260 · Cited by 24
Correlation between protein YKL-40 and ultrasonographic findings in active knee osteoarthritis
Karalilova, R. V., Kazakova, M., Batalov, A. Z., & Sarafian, V. S. (2018) · Medical Ultrasonography · doi:10.11152/mu-1247 · Cited by 24
Nemirovskiy, O. V., Sunyer, T., Aggarwal, P., Abrams, M. A., Graverand, M.-P. H. L., & Mathews, W. R. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.04.021 · Cited by 24
Savarino, L., Granchi, D., Cenni, E., Baldini, N., Gréco, M., & Giunti, A. (2005) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.87b4.15316 · Cited by 24
Tomonaga, A., Takahashi, T., Tanaka, Y., Tsuboi, M., Ito, K., & Nagaoka, I. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4454 · Cited by 24
Biochemical markers of bone turnover and their association with bone marrow lesions
Hunter, D. J., LaValley, M. P., Jiang, L., Bauer, D. C., Nevitt, M. C., DeGroot, J., Poole, R., Eyre, D. R., Guermazi, A., Gale, D. R., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2494 · Cited by 23
Mazzuca, S. A., Brandt, K. D., Eyre, D. R., Katz, B. P., Askew, J., & Lane, K. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041582 · Cited by 23
[Leptin: a link between obesity and osteoarthritis?].
Pottie, P., Presle, N., Dumond, H., Terlain, B. L., Mainard, D., Leuille, D., & Netter, P. (2004) · Arthritis Research · doi:10.1186/ar1342 · Cited by 23
Das, B., Roy, A., & Khan, F. (2015) · Perspectives in Clinical Research · doi:10.4103/2229-3485.148792 · Cited by 22
Suo, J., Gan, Y., Xie, Y., Xu, S., Wang, J., Chen, D., Chen, L., Deng, L., Feng, S., Han, J. J., et al. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad045 · Cited by 23
Denning, W. M., Woodland, S. T., Winward, J. G., Leavitt, M., Parcell, A. C., Hopkins, J. T., Francom, D., & Seeley, M. K. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.05.006 · Cited by 22
Aslam, I., Perjar, I., Shi, X., Renner, J. B., Kraus, V. B., Golightly, Y. M., Jordan, J. M., & Nelson, A. E. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130904 · Cited by 22
Dreiner, M., Willwacher, S., Krämer, A., Kümmel, J., Frett, T., Zaucke, F., Liphardt, A., Grüber, M., & Niehoff, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01032 · Cited by 24
Sumer, E. U., Schaller, S., Søndergaard, B. C., Tankó, L. B., & Qvist, P. (2006) · Biomarkers · doi:10.1080/13547500600886115 · Cited by 22
Kumar, R. R., Sporn, K., Paladugu, P., Khanna, A., Gowda, C., Ngo, A., Waisberg, E., Ong, J., Jagadeesan, R., & Tavakkoli, A. (2025) · Diagnostics · doi:10.3390/diagnostics15131648 · Cited by 22
Hernández‐Hermoso, J. A., Nescolarde, L., Roca, E., Revuelta‐López, E., Ara, J., & Bayés‐Genís, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.722718 · Cited by 21
Wang, M. L., & Peng, Z. (2015) · Biosurface and Biotribology · doi:10.1016/j.bsbt.2015.06.003 · Cited by 21
Hyaluronic acid concentrations in synovial fluid of dogs with different stages of osteoarthritis
Plickert, H. D., Bondzio, A., Einspanier, R., Tichy, A., & Brunnberg, L. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.11.007 · Cited by 21
Alleviation of Cartilage Destruction by Sinapic Acid in Experimental Osteoarthritis
Cai, D., Huff, T. W., Liu, J., Yuan, T., Wei, Z., & Qin, J. (2019) · BioMed Research International · doi:10.1155/2019/5689613 · Cited by 21
Zhu, Z., Jin, X., Wang, B. H., Wluka, A. E., Antony, B., Laslett, L. L., Winzenberg, T. M., Cicuttini, F., Jones, G., & Ding, C. (2016) · Arthritis Care & Research · doi:10.1002/acr.22834 · Cited by 20
Streich, N. A., Zimmermann, D., Schmitt, H., & Bode, G. (2011) · International Orthopaedics · doi:10.1007/s00264-010-1191-5 · Cited by 20
Gonzalez-Fuentes, A. M., Green, D. M., Rossen, R. D., & Ng, B. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1376-8 · Cited by 20
Influence of corticosteroids on C-reactive protein in patients with rheumatoid arthritis
Mysler, E., Psioni, C., Tate, P., & Tate, G. (2004) · Arthritis Research · doi:10.1186/ar1392 · Cited by 20
Characterizing human subchondral bone properties using near-infrared (NIR) spectroscopy
Afara, I. O., Florea, C., Olumegbon, I. A., Eneh, C. T. M., Malo, M. K. H., Korhonen, R. K., & Töyräs, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27786-3 · Cited by 19
Riegger, J., Rehm, M., Büchele, G., Brenner, H., Günther, K., Rothenbacher, D., & Brenner, R. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010268 · Cited by 19
Zhang, K., Shi, J., Yang, L., Jiang, Y., Tao, T., Li, W., & Gui, J. (2016) · Journal of Molecular Histology · doi:10.1007/s10735-016-9668-1 · Cited by 18
Metadata
- Authors
- Garnero, P., Piperno, M., Gineyts, E., Christgau, S., Delmas, P. D., & Vignon, E.
- Affiliations
- Inserm (FR)
- Corresponding author
- Garnero, P
- ORCID
- Garnero, P
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 60
- Issue
- 6
- Pages
- 619-626
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2125310185
- Cited by
- 475
- References
- 62
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 11 · 2023: 10 · 2022: 7 · 2021: 13 · 2020: 18 · 2019: 16 · 2018: 17 · 2017: 13 · 2016: 13 · 2015: 20 · 2014: 21 · 2013: 14 · 2012: 18
- FWCI
- 29.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of the Rheumatic Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- knee osteoarthritis, biochemical markers, type II collagen, C-terminal telopeptide, cartilage metabolism, bone turnover markers, osteocalcin, cartilage oligomeric matrix protein, YKL-40, hyaluronic acid, disease activity, joint destruction
- MeSH terms
- Aged, Aged, 80 and over, Amino Acids, Bone and Bones, Cartilage, Articular, Collagen, Cross-Sectional Studies, Female, Galactosides, Humans, Knee Joint, Male, Middle Aged, Peptide Fragments, Peptides, Procollagen, Radiography, Severity of Illness Index, Synovial Membrane, Biomarkers, Body Mass Index, Multivariate Analysis, Osteoarthritis, Knee, Collagen Type I, Collagen Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review